CD42 Antibodies

Santa Cruz Biotechnology provides a broad selection of CD42 monoclonal antibodies for researchers studying platelet biology and related processes. CD42 monoclonal antibodies perform effectively in western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD42, also known as the platelet glycoprotein complex, plays a crucial role in platelet adhesion and aggregation, making it vital for hemostasis and thrombosis. Understanding CD42 function is important for developing therapies for cardiovascular diseases and other conditions related to platelet dysfunction. The study of CD42 can provide insights into the mechanisms of immune responses and inflammation. CD42 monoclonal antibodies enable precise detection and analysis of platelet activity in various experimental settings. Researchers can track CD42 expression patterns across different tissue types and cellular conditions. CD42 monoclonal antibodies support investigations into blood disorders and potential therapeutic interventions. Santa Cruz Biotechnology monoclonal antibodies for CD42 contribute to advancing platelet research and cardiovascular medicine within the scientific community.